# Savara Inc

Savara Inc is a public company listed on Nasdaq as SVRA, headquartered in Austin, TX, United States.

## Company overview

- **Legal name:** Savara Inc
- **Former names in filing history:** Mast Therapeutics, Inc. (2013-03-12 to 2017-04-25); ADVENTRX PHARMACEUTICALS INC (2003-08-14 to 2013-03-01); BIOKEYS PHARMACEUTICALS INC (2001-10-02 to 2003-05-15)
- **Classification:** Public company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Austin, TX, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **Ticker:** Nasdaq: SVRA
- **SEC CIK:** 0001160308

## About

Savara Inc is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001160308, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-03-13, it reported net income of USD -118,837,000; total assets of USD 253,436,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2025 (period ended 2025-12-31)

- **Net income:** -$118.8M (USD -118,837,000)
- **Total assets:** $253.4M (USD 253,436,000)
- **Cash and equivalents:** $33.2M (USD 33,180,000)
- **Operating cash flow:** -$101.0M (USD -101,037,000)

### FY2024 (period ended 2024-12-31)

- **Net income:** -$95.9M (USD -95,881,000)
- **Total assets:** $212.9M (USD 212,879,000)
- **Cash and equivalents:** $15.1M (USD 15,128,000)
- **Operating cash flow:** -$89.1M (USD -89,088,000)

### FY2023 (period ended 2023-12-31)

- **Net income:** -$54.7M (USD -54,698,000)
- **Total assets:** $177.6M (USD 177,564,000)
- **Cash and equivalents:** $26.6M (USD 26,585,000)
- **Operating cash flow:** -$51.1M (USD -51,061,000)

### FY2022 (period ended 2022-12-31)

- **Net income:** -$38.1M (USD -38,150,000)
- **Total assets:** $139.8M (USD 139,777,000)
- **Cash and equivalents:** $52.1M (USD 52,100,000)
- **Operating cash flow:** -$34.6M (USD -34,554,000)

## Recent SEC filings

- Form 10-Q — filed 2026-08-11 — period 2026-06-30 — 10-Q
- Form 8-K — filed 2026-06-08 — period 2026-06-04 — 8-K
- Form 10-Q — filed 2026-05-12 — period 2026-03-31 — 10-Q
- Form DEF 14A — filed 2026-04-24 — period 2026-06-04 — DEF 14A
- Form 8-K — filed 2026-03-13 — period 2026-03-10 — 8-K
- Form 10-K — filed 2026-03-13 — period 2025-12-31 — 10-K
- Form 8-K — filed 2026-01-27 — period 2026-01-26 — 8-K
- Form 8-K — filed 2026-01-09 — period 2026-01-09 — 8-K
- Form 10-Q — filed 2025-11-12 — period 2025-09-30 — 10-Q
- Form 8-K — filed 2025-10-30 — period 2025-10-29 — 8-K
- Form 8-K — filed 2025-10-29 — period 2025-10-29 — 8-K
- Form 8-K — filed 2025-09-02 — period 2025-09-02 — 8-K

---

Updated: 2026-10-23T05:02:54.863002+00:00

Canonical page: https://altss.com/profile/savara-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology